Item 5.07. Submission of Matters to a Vote of Security Holders. At the 2022 annual meeting of stockholders of ICU Medical, Inc. (the "Company") held on May 17, 2022, the following proposals were voted on by the Company's stockholders, and the results were as set forth below:

Proposal 1. Election of directors.




             Name of Nominee          Votes For        Withheld         Broker Non-Votes
         Vivek Jain                   20,884,442        507,092             761,531
         George A. Lopez, M.D.        21,336,260        55,274              761,531
         David C. Greenberg           21,111,298        280,236             761,531
         Elisha W. Finney             20,928,741        462,793             761,531
         David F. Hoffmeister         19,888,047       1,503,487            761,531
         Donald M. Abbey              21,018,209        373,325             761,531
         Laurie Hernandez             21,377,083        14,451              761,531
         Kolleen T. Kennedy           21,378,371        13,163              761,531
         William Seeger               21,377,964        13,570              761,531


The Company's stockholders elected each of the director nominees to serve as a director until the next annual meeting of stockholders or until their respective successors are elected and qualified.



Proposal 2. Ratification of the appointment of Deloitte & Touche LLP as the
Company's independent registered public accounting firm for the fiscal year
ending December 31, 2022.


             Votes For         Votes Against         Abstain         Broker Non-Votes
             21,245,122           901,415             6,528                 -


The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.



Proposal 3. Approve the advisory vote on the Company's named executive officer
compensation.


             Votes For         Votes Against         Abstain         Broker Non-Votes
             21,178,194           200,369            12,971              761,531


The Company's stockholders approved, on an advisory basis, the Company's named executive officer compensation.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses